Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,154.17
-15.97 (-1.36%)
Streaming Delayed Price
Updated: 2:55 PM EDT, Sep 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,194,365
Open
1,174.71
Bid (Size)
1,153.84 (80)
Ask (Size)
1,154.35 (40)
Prev. Close
1,170.14
Today's Range
1,145.98 - 1,188.88
52wk Range
712.05 - 1,292.65
Shares Outstanding
956,580,893
Dividend Yield
0.60%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Could Retatrutide Be Worth $10 Billion to Eli Lilly?
↗
Today 14:05 EDT
The company continues to dominate the weight loss market.
Via
The Motley Fool
Topics
Law Enforcement
Viking's Obesity Edge May Be Staying Power, Not Weight Loss
↗
Today 13:20 EDT
Viking Therapeutics shares jumped 36% after VK2735 maintenance data showed patients kept most weight loss on less frequent dosing, though Phase 3 results and commercial funding remain unresolved.
Via
MarketBeat
Performance
YTD
+6.8%
+6.8%
1 Month
-7.4%
-7.4%
3 Month
+4.3%
+4.3%
6 Month
+27.8%
+27.8%
1 Year
+52.9%
+52.9%
More News
Read More
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
↗
Today 9:15 EDT
Via
MarketBeat
Topics
Intellectual Property
Lawsuit
Eli Lilly (NYSE:LLY) Fits a Dividend Quality Screen Despite Its Low Yield
↗
September 18, 2026
Via
Chartmill
Why Viking Therapeutics Stock Skyrocketed on Tuesday
↗
Today 0:24 EDT
Via
The Motley Fool
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH
↗
September 22, 2026
Via
The Motley Fool
Topics
ETFs
Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems
↗
September 22, 2026
Via
The Motley Fool
VHT vs. XBI: Is Diversified Healthcare Exposure or Biotech Stocks the Smarter Choice for Investors?
↗
September 22, 2026
Via
The Motley Fool
Topics
ETFs
Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
↗
September 22, 2026
Via
MarketBeat
Topics
Initial Public Offering
Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?
↗
September 22, 2026
Via
The Motley Fool
Topics
Economy
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
↗
September 22, 2026
Via
Investor's Business Daily
2 Cash-Producing Stocks with Exciting Potential and 1 We Brush Off
September 22, 2026
Via
StockStory
VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem
September 21, 2026
Via
AB Newswire
Topics
Animal Testing
Eli Lilly Stock Is On Track to Do Something It Hasn't Done Since 2016
↗
September 21, 2026
Via
The Motley Fool
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Down
↗
September 20, 2026
Via
The Motley Fool
Topics
ETFs
Why Twist Bioscience Stock Skyrocketed This Week
↗
September 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Better Buy for Cautious Investors: Eli Lilly vs Costco
↗
September 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Automated Labeling Tools Are Modernizing the AI Training Dataset Market
↗
September 18, 2026
Via
Talk Markets
Topics
Artificial Intelligence
1 Safe-and-Steady Stock Worth Your Attention and 2 We Question
September 18, 2026
Via
StockStory
Topics
Emissions
Wall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic.
↗
September 17, 2026
Via
The Motley Fool
This Trend is Excellent News for Eli Lilly and Its Investors
↗
September 17, 2026
Via
The Motley Fool
Does Fidelity or iShares Have the Better Healthcare ETF For Investors Seeking Broad Exposure?
↗
September 16, 2026
Via
The Motley Fool
Topics
ETFs
5 Buy-and-Hold Stocks Built to Weather a Volatile Market
↗
September 16, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?
↗
September 16, 2026
Via
The Motley Fool
Topics
Economy
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
↗
September 15, 2026
Via
The Motley Fool
Topics
ETFs
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,154.17
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 09/23/26 02:55 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,104.06B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,104B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
